These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34273512)

  • 21. Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination.
    Amanat F; Clark J; Carreño JM; Strohmeier S; Yellin T; Meade PS; Bhavsar D; Muramatsu H; Sun W; Coughlan L; Pardi N; Krammer F
    J Virol; 2023 Mar; 97(3):e0166422. PubMed ID: 36779758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
    Braun J; Loyal L; Frentsch M; Wendisch D; Georg P; Kurth F; Hippenstiel S; Dingeldey M; Kruse B; Fauchere F; Baysal E; Mangold M; Henze L; Lauster R; Mall MA; Beyer K; Röhmel J; Voigt S; Schmitz J; Miltenyi S; Demuth I; Müller MA; Hocke A; Witzenrath M; Suttorp N; Kern F; Reimer U; Wenschuh H; Drosten C; Corman VM; Giesecke-Thiel C; Sander LE; Thiel A
    Nature; 2020 Nov; 587(7833):270-274. PubMed ID: 32726801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional SARS-CoV-2 cross-reactive CD4
    Humbert M; Olofsson A; Wullimann D; Niessl J; Hodcroft EB; Cai C; Gao Y; Sohlberg E; Dyrdak R; Mikaeloff F; Neogi U; Albert J; Malmberg KJ; Lund-Johansen F; Aleman S; Björkhem-Bergman L; Jenmalm MC; Ljunggren HG; Buggert M; Karlsson AC
    Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2220320120. PubMed ID: 36917669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severities.
    Imai K; Matsuoka M; Tabata S; Kitagawa Y; Nagura-Ikeda M; Kubota K; Fukada A; Takada T; Sato M; Noguchi S; Takeuchi S; Arakawa N; Miyoshi K; Saito Y; Maeda T
    Int J Infect Dis; 2021 Oct; 111():68-75. PubMed ID: 34407480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.
    Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A
    Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-reactive cellular, but not humoral, immunity is detected between OC43 and SARS-CoV-2 NPs in people not infected with SARS-CoV-2: Possible role of cT
    García-Jiménez ÁF; Cáceres-Martell Y; Fernández-Soto D; Martínez Fleta P; Casasnovas JM; Sánchez-Madrid F; Frade JMR; Valés-Gómez M; Reyburn HT
    J Leukoc Biol; 2022 Aug; 112(2):339-346. PubMed ID: 35384035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63.
    Saletti G; Gerlach T; Jansen JM; Molle A; Elbahesh H; Ludlow M; Li W; Bosch BJ; Osterhaus ADME; Rimmelzwaan GF
    Sci Rep; 2020 Dec; 10(1):21447. PubMed ID: 33293664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19.
    Dugas M; Grote-Westrick T; Merle U; Fontenay M; Kremer AE; Hanses F; Vollenberg R; Lorentzen E; Tiwari-Heckler S; Duchemin J; Ellouze S; Vetter M; Fürst J; Schuster P; Brix T; Denkinger CM; Müller-Tidow C; Schmidt H; Tepasse PR; Kühn J
    J Clin Virol; 2021 Jun; 139():104847. PubMed ID: 33965698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1).
    Dugas M; Grote-Westrick T; Vollenberg R; Lorentzen E; Brix T; Schmidt H; Tepasse PR; Kühn J
    Int J Infect Dis; 2021 Apr; 105():304-306. PubMed ID: 33636357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada.
    Tanunliong G; Liu AC; Kaweski S; Irvine M; Reyes RC; Purych D; Krajden M; Morshed M; Sekirov I; Gantt S; Skowronski DM; Jassem AN
    Front Immunol; 2022; 13():836449. PubMed ID: 35401521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epitope-directed anti-SARS-CoV-2 scFv engineered against the key spike protein region could block membrane fusion.
    Jaiswal D; Kumar U; Gaur V; Salunke DM
    Protein Sci; 2023 Mar; 32(3):e4575. PubMed ID: 36691733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do Sputnik V Vaccine-Induced Antibodies Protect Against Seasonal Coronaviruses? Case Study.
    Koryukov M; Kechin A; Shamovskaya D; Timofeeva A; Filipenko M
    Viral Immunol; 2022 Mar; 35(2):138-141. PubMed ID: 35143357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients.
    Ruetalo N; Businger R; Althaus K; Fink S; Ruoff F; Pogoda M; Iftner A; Ganzenmüller T; Hamprecht K; Flehmig B; Bakchoul T; Templin MF; Schindler M
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33627511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2.
    Sun X; Yi C; Zhu Y; Ding L; Xia S; Chen X; Liu M; Gu C; Lu X; Fu Y; Chen S; Zhang T; Zhang Y; Yang Z; Ma L; Gu W; Hu G; Du S; Yan R; Fu W; Yuan S; Qiu C; Zhao C; Zhang X; He Y; Qu A; Zhou X; Li X; Wong G; Deng Q; Zhou Q; Lu H; Ling Z; Ding J; Lu L; Xu J; Xie Y; Sun B
    Nat Microbiol; 2022 Jul; 7(7):1063-1074. PubMed ID: 35773398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of Chicken IgY against SARS-COV-2 Spike Protein and Epitope Mapping.
    Lu Y; Wang Y; Zhang Z; Huang J; Yao M; Huang G; Ge Y; Zhang P; Huang H; Wang Y; Li H; Wang W
    J Immunol Res; 2020; 2020():9465398. PubMed ID: 33134398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43.
    Che XY; Qiu LW; Liao ZY; Wang YD; Wen K; Pan YX; Hao W; Mei YB; Cheng VC; Yuen KY
    J Infect Dis; 2005 Jun; 191(12):2033-7. PubMed ID: 15897988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.
    Zheng Z; Monteil VM; Maurer-Stroh S; Yew CW; Leong C; Mohd-Ismail NK; Cheyyatraivendran Arularasu S; Chow VTK; Lin RTP; Mirazimi A; Hong W; Tan YJ
    Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
    J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.